CNBC’s Meg Tirrell reports biotech companies are watching what will be included in President Trump’s executive order on drug pricing, and the industry is optimistic about new products in the pipeline.
Source: Drug pricing weighs on biotech
- Market Snapshot: Stock market books weekly, daily gain as tech and energy sectors rallyHowever, health-care stocks surrender Thursday’s gainsU.S. stocks finish mostly higher Friday as investors scoop up ... read more2 hours ago
- Japanese plant padded paracetamol with cheap Chinese importsActive ingredients supplier Yamamoto Chemical Industry has been blocked from shipping its products after… ... read more8 hours ago
- Worm studies investigate how grandparents’ experiences can affect our genesIn the hot field of epigenetics, Susan Strome's lab is studying tiny roundworms to understand ... read more1 day ago
To access all our news feeds tap “Headlines“.